Clinical Trials in Chicago

Showing 11001-11020 of 20,493 trials

Skin Tone Preferences and Their Influence on Skin Care Behaviors

NCT03651167

The purpose of this study is to classify participants by actual skin tone and skin tone preference and identify whether an association exists between these skin tone preferences and knowledge of skin care recommendations, attitudes towards healthy skin care, or skin care behaviors.

Dermatology/Skin - Other

Northwestern University619 participantsStarted Aug 2018

Chicago, Illinois, United States

COMPLETEDPhase 12.2 miles

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

NCT01968083

Human respiratory syncytial virus (RSV) is a common cause of respiratory illness in infants and children. This study will evaluate the safety and immune response to an RSV vaccine in healthy RSV-naïve children.

Respiratory Syncytial Virus Infections

National Institute of Allergy and Infectious Diseases (NIAID)51 participantsStarted Oct 2013

La Jolla, California, United States • Long Beach, California, United States • Denver, Colorado, United States +2 more locations

TERMINATED2.2 miles

Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion

NCT04232189

This will be a case-series multicenter study enrolling 800 pregnant people. Serum will be collected from people seeking abortion and assayed at a qualified laboratory.

Pregnancy

Gynuity Health Projects275 participantsStarted Nov 2019

West Palm Beach, Florida, United States • Chicago, Illinois, United States • New York, New York, United States

Skin Tone Preferences and Their Influence on Skin Care Behaviors

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion

Find Trials by Condition in Chicago

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

Scoring System for Inhalation Injury

Effect of Body Position and Probe Position on the Localization of Breast Mass

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Alcohol and Implicit Process in Sexual Risk Behavior in MSM

A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma

PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia